{"count": 184, "results": [{"_id": "34367059", "pmid": 34367059, "pmcid": "PMC8342037", "title": "Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit", "journal": "Front Endocrinol (Lausanne)", "authors": ["Ibrahim S", "Lowe JR", "Bramante CT", "Shah S", "Klatt NR", "Sherwood N", "Aronne L", "Puskarich M", "Tamariz L", "Palacio A", "Bomberg E", "Usher M", "King S", "Benson B", "Vojta D", "Tignanelli C", "Ingraham N"], "date": "2021-07-22T00:00:00Z", "doi": "10.3389/fendo.2021.587801", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "587801", "score": 50265.086, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@Covid-19@@@: Focused Review of Mechanisms and Current Literature Suggesting Benefit", "citations": {"NLM": "Ibrahim S, Lowe JR, Bramante CT, Shah S, Klatt NR, Sherwood N, Aronne L, Puskarich M, Tamariz L, Palacio A, Bomberg E, Usher M, King S, Benson B, Vojta D, Tignanelli C, Ingraham N. Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit Front Endocrinol (Lausanne). 2021;12():587801. PMID: 34367059", "BibTeX": "@article{34367059, title={Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit}, author={Ibrahim S and Lowe JR and Bramante CT and Shah S and Klatt NR and Sherwood N and Aronne L and Puskarich M and Tamariz L and Palacio A and Bomberg E and Usher M and King S and Benson B and Vojta D and Tignanelli C and Ingraham N}, journal={Front Endocrinol (Lausanne)}, volume={12}, pages={587801}}"}}, {"_id": "37646067", "pmid": 37646067, "pmcid": "PMC10460805", "title": "Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19", "journal": "Adv Pharm Bull", "authors": ["Shaseb E", "Ghaffary S", "Garjani A", "Zoghi E", "Maleki Dizaji N", "Soltani S", "Sarbakhsh P", "Somi MH", "Valizadeh P", "Taghizadieh A", "Faghihdinevari M", "Varshochi M", "Naghily B", "Bayatmakoo Z", "Saleh P", "Taghizadeh S", "Haghdoost M", "Owaysi H", "Ravanbakhsh Ghavghani F", "Tarzamni MK", "Moradi R", "Javan Ali Azar F", "Shabestari Khiabani S", "Ghazanchaei A", "Hamedani S", "Hatefi S"], "date": "2023-07-01T00:00:00Z", "doi": "10.34172/apb.2023.066", "meta_date_publication": "2023 Jul", "meta_volume": "13", "meta_issue": "3", "meta_pages": "621-626", "score": 50265.008, "text_hl": "Long and Short-term @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Consumption as a Potential Therapy to Prevent Complications of @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@", "citations": {"NLM": "Shaseb E, Ghaffary S, Garjani A, Zoghi E, Maleki Dizaji N, Soltani S, Sarbakhsh P, Somi MH, Valizadeh P, Taghizadieh A, Faghihdinevari M, Varshochi M, Naghily B, Bayatmakoo Z, Saleh P, Taghizadeh S, Haghdoost M, Owaysi H, Ravanbakhsh Ghavghani F, Tarzamni MK, Moradi R, Javan Ali Azar F, Shabestari Khiabani S, Ghazanchaei A, Hamedani S, Hatefi S. Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19 Adv Pharm Bull. 2023 Jul;13(3):621-626. PMID: 37646067", "BibTeX": "@article{37646067, title={Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19}, author={Shaseb E and Ghaffary S and Garjani A and Zoghi E and Maleki Dizaji N and Soltani S and Sarbakhsh P and Somi MH and Valizadeh P and Taghizadieh A and Faghihdinevari M and Varshochi M and Naghily B and Bayatmakoo Z and Saleh P and Taghizadeh S and Haghdoost M and Owaysi H and Ravanbakhsh Ghavghani F and Tarzamni MK and Moradi R and Javan Ali Azar F and Shabestari Khiabani S and Ghazanchaei A and Hamedani S and Hatefi S}, journal={Adv Pharm Bull}, volume={13}, number={3}, pages={621-626}}"}}, {"_id": "36355535", "pmid": 36355535, "pmcid": "PMC9699540", "title": "Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19", "journal": "Pharmaceuticals (Basel)", "authors": ["Al-Kuraishy HM", "Al-Gareeb AI", "Albogami SM", "Jean-Marc S", "Nadwa EH", "Hafiz AA", "A Negm W", "Kamal M", "Al-Jouboury M", "Elekhnawy E", "Batiha GE", "Waard M"], "date": "2022-11-07T00:00:00Z", "doi": "10.3390/ph15111361", "meta_date_publication": "2022 Nov 7", "meta_volume": "15", "meta_issue": "11", "meta_pages": "", "score": 50264.707, "text_hl": "However, OSI was low in mild-moderate @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ plus @CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@sitagliptin@@@ treatment (2.12 +- 0.09) relative to severe @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ @SPECIES_9606 @@@patients@@@ on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy (p = 0.001) (Figure 4C). ", "citations": {"NLM": "Al-Kuraishy HM, Al-Gareeb AI, Albogami SM, Jean-Marc S, Nadwa EH, Hafiz AA, A Negm W, Kamal M, Al-Jouboury M, Elekhnawy E, Batiha GE, Waard M. Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19 Pharmaceuticals (Basel). 2022 Nov 7;15(11):. PMID: 36355535", "BibTeX": "@article{36355535, title={Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19}, author={Al-Kuraishy HM and Al-Gareeb AI and Albogami SM and Jean-Marc S and Nadwa EH and Hafiz AA and A Negm W and Kamal M and Al-Jouboury M and Elekhnawy E and Batiha GE and Waard M}, journal={Pharmaceuticals (Basel)}, volume={15}, number={11}}"}}, {"_id": "35370738", "pmid": 35370738, "pmcid": "PMC8964397", "title": "Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin", "journal": "Front Pharmacol", "authors": ["Bailey CJ", "Gwilt M"], "date": "2022-03-09T00:00:00Z", "doi": "10.3389/fphar.2022.784459", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "784459", "score": 50264.69, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@Covid-19@@@", "citations": {"NLM": "Bailey CJ, Gwilt M. Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin Front Pharmacol. 2022;13():784459. PMID: 35370738", "BibTeX": "@article{35370738, title={Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin}, author={Bailey CJ and Gwilt M}, journal={Front Pharmacol}, volume={13}, pages={784459}}"}}, {"_id": "33310173", "pmid": 33310173, "pmcid": "PMC7833191", "title": "Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study", "journal": "Diabetes Res Clin Pract", "authors": ["Jiang N", "Chen Z", "Liu L", "Yin X", "Yang H", "Tan X", "Wang J", "Li H", "Tian M", "Lu Z", "Xiong N", "Gong Y"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.diabres.2020.108619", "meta_date_publication": "2021 Mar", "meta_volume": "173", "meta_issue": "", "meta_pages": "108619", "score": 50263.863, "text_hl": "There was no significant difference in severity of @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ between the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and the non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group (P = 0.2552). ", "citations": {"NLM": "Jiang N, Chen Z, Liu L, Yin X, Yang H, Tan X, Wang J, Li H, Tian M, Lu Z, Xiong N, Gong Y. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study Diabetes Res Clin Pract. 2021 Mar;173():108619. PMID: 33310173", "BibTeX": "@article{33310173, title={Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study}, author={Jiang N and Chen Z and Liu L and Yin X and Yang H and Tan X and Wang J and Li H and Tian M and Lu Z and Xiong N and Gong Y}, journal={Diabetes Res Clin Pract}, volume={173}, pages={108619}}"}}, {"_id": "34490296", "pmid": 34490296, "pmcid": "PMC8416892", "title": "Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis", "journal": "Front Med (Lausanne)", "authors": ["Li Y", "Yang X", "Yan P", "Sun T", "Zeng Z", "Li S"], "date": "2021-08-19T00:00:00Z", "doi": "10.3389/fmed.2021.704666", "meta_date_publication": "2021", "meta_volume": "8", "meta_issue": "", "meta_pages": "704666", "score": 50263.74, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@: A Systematic Review and Meta-Analysis", "citations": {"NLM": "Li Y, Yang X, Yan P, Sun T, Zeng Z, Li S. Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis Front Med (Lausanne). 2021;8():704666. PMID: 34490296", "BibTeX": "@article{34490296, title={Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis}, author={Li Y and Yang X and Yan P and Sun T and Zeng Z and Li S}, journal={Front Med (Lausanne)}, volume={8}, pages={704666}}"}}, {"_id": "33679040", "pmid": 33679040, "pmcid": "PMC7922709", "title": "Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus?", "journal": "Int J Diabetes Dev Ctries", "authors": ["Lazarus G", "Suhardi IP", "Wiyarta E", "Rasyidah RA", "Barliana JD"], "date": "2021-07-01T00:00:00Z", "doi": "10.1007/s13410-021-00924-w", "meta_date_publication": "2021 Jul", "meta_volume": "41", "meta_issue": "3", "meta_pages": "377-382", "score": 50263.33, "text_hl": "This study aims to investigate the association between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and poor @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ outcomes.", "citations": {"NLM": "Lazarus G, Suhardi IP, Wiyarta E, Rasyidah RA, Barliana JD. Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus? Int J Diabetes Dev Ctries. 2021 Jul;41(3):377-382. PMID: 33679040", "BibTeX": "@article{33679040, title={Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus?}, author={Lazarus G and Suhardi IP and Wiyarta E and Rasyidah RA and Barliana JD}, journal={Int J Diabetes Dev Ctries}, volume={41}, number={3}, pages={377-382}}"}}, {"_id": "34664036", "pmid": 34664036, "pmcid": "PMC8516148", "title": "A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19", "journal": "Metabol Open", "authors": ["Kifle ZD", "Woldeyohanis AE", "Demeke CA"], "date": "2021-12-01T00:00:00Z", "doi": "10.1016/j.metop.2021.100137", "meta_date_publication": "2021 Dec", "meta_volume": "12", "meta_issue": "", "meta_pages": "100137", "score": 50262.977, "text_hl": "The beneficial mechanism of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ against @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@.", "citations": {"NLM": "Kifle ZD, Woldeyohanis AE, Demeke CA. A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19 Metabol Open. 2021 Dec;12():100137. PMID: 34664036", "BibTeX": "@article{34664036, title={A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19}, author={Kifle ZD and Woldeyohanis AE and Demeke CA}, journal={Metabol Open}, volume={12}, pages={100137}}"}}, {"_id": "37194484", "pmid": 37194484, "title": "Metformin as a potential treatment for COVID-19.", "journal": "Expert Opin Pharmacother", "authors": ["MCCarthy MW"], "date": "2023-05-18T00:00:00Z", "doi": "10.1080/14656566.2023.2215385", "meta_date_publication": "2023 May 18", "meta_volume": "", "meta_issue": "", "meta_pages": "1-5", "score": 50262.777, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as a potential treatment for @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@.", "citations": {"NLM": "MCCarthy MW. Metformin as a potential treatment for COVID-19. Expert Opin Pharmacother. 2023 May 18;():1-5. PMID: 37194484", "BibTeX": "@article{37194484, title={Metformin as a potential treatment for COVID-19.}, author={MCCarthy MW}, journal={Expert Opin Pharmacother}, pages={1-5}}"}}, {"_id": "34699977", "pmid": 34699977, "pmcid": "PMC8536836", "title": "The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation", "journal": "Diabetes Metab", "authors": ["Al-Salameh A", "Bennis Y", "Cariou B", "Lalau JD"], "date": "2021-11-01T00:00:00Z", "doi": "10.1016/j.diabet.2021.101297", "meta_date_publication": "2021 Nov", "meta_volume": "47", "meta_issue": "6", "meta_pages": "101297", "score": 50262.6, "text_hl": "The association between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment and @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ outcomes according to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ continuation during hospitalisation", "citations": {"NLM": "Al-Salameh A, Bennis Y, Cariou B, Lalau JD. The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation Diabetes Metab. 2021 Nov;47(6):101297. PMID: 34699977", "BibTeX": "@article{34699977, title={The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation}, author={Al-Salameh A and Bennis Y and Cariou B and Lalau JD}, journal={Diabetes Metab}, volume={47}, number={6}, pages={101297}}"}}]}